About Artificial Intelligence companies in HealthTech in Asia
There are 562 Artificial Intelligence companies in HealthTech in Asia, including 240 funded companies having collectively raised $5.79B in venture capital money and private equity. Out of these, 100 are Series A+ funded, and 3 have achieved unicorn status.
Artificial Intelligence companies in HealthTech in Asia has seen 3 acquisitions and 6 IPOs.
HealthTech sector is also known as Digital Health, e-Health, Health And Wellness Tech, Smart Healthcare, Healthcare Technology or Health Management Technology.
Top Artificial Intelligence companies in HealthTech in Asia
There are more than 562 Artificial Intelligence companies in HealthTech in Asia. Innovaccer is the top Artificial Intelligence company in HealthTech in Asia, ranked using Tracxn Score (what's this?).
Here are 5 of the top Artificial Intelligence companies in HealthTech in Asia:
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Developer of healthcare data platforms and artificial intelligence agent software | San Francisco (United States) | 2014 | Series F | $675M | |
Developer of artificial intelligence software for medical imaging diagnostic analysis | Mumbai (India) | 2016 | Series D | $123M | |
Developer of medical software for cancer screening and oncology diagnostics | Seoul (South Korea) | 2013 | Public | $135M | |
Provider of AI-powered diagnostic solutions for pathology | Tel Aviv (Israel) | 2016 | Series C | $114M | |
Provider of an AI-powered operating system for healthcare marketing solutions | Short Hills (United States) | 2020 | Series B | $64.8M |
Artificial Intelligence companies founded year-on-year in HealthTech in Asia
25 new startups have been founded so far in 2026 in Artificial Intelligence companies in HealthTech in Asia. 54 Artificial Intelligence startups in HealthTech in Asia were founded in 2020 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | 25 |
2025 | 42 |
2024 | 42 |
2023 | 38 |
2022 | 21 |
2021 | 49 |
2020 | 54 |
2019 | 50 |
2018 | 38 |
2017 | 43 |
Stage-wise distribution of Artificial Intelligence companies in HealthTech in Asia
Out of the total 562 Artificial Intelligence companies in HealthTech in Asia, 240 have secured funding. Among them, 100 have reached Series A or higher, and 55 to Series B or beyond.
Founded - 562
Funded - 240
Series A+ - 100
Series B+ - 55
Series C+ - 34
Company Stage | No. of companies |
|---|---|
Founded | 562 |
Funded | 240 |
Series A+ | 100 |
Series B+ | 55 |
Series C+ | 34 |
Let us walk you through our Sectors and other offerings
Designed with precision for VCs, PE, IBs, Incubators, M&A, Innovation more
Designed with precision for VCs, PE, IBs, Incubators, M&A, Innovation more
Funding Trends in Artificial Intelligence companies in HealthTech in Asia
Total funding year-on-year in Artificial Intelligence companies in HealthTech in Asia
Artificial Intelligence companies in HealthTech in Asia saw a total funding of more than $5.09B in the last 10 years. The most amount of funding was in 2021 at more than $1.28B. There has been a total funding of $356M in 2026 till date.
- Total Funding
Year | Total Funding |
|---|---|
2026 | $356M |
2025 | $608M |
2024 | $260M |
2023 | $335M |
2022 | $485M |
2021 | $1.28B |
2020 | $466M |
2019 | $201M |
2018 | $978M |
2017 | $123M |
Recent Funding Rounds in Artificial Intelligence companies in HealthTech in Asia
In the year 2026, till September 2026, Artificial Intelligence companies in HealthTech in Asia have raised $335M in equity funding across 22 rounds.
In the same period last year (i.e. till September 2025), Artificial Intelligence companies in HealthTech in Asia had raised $343M across 23 rounds.
So, 2026 has seen a 2.6% drop in funding in Artificial Intelligence companies in HealthTech in Asia as compared to 2025.
Here are some recent, important funding rounds in Artificial Intelligence companies in HealthTech in Asia:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Seed | 3635 | Sep 02, 2026 | ||
Series A | 5138 | Aug 06, 2026 | ||
Series B | 5013 | Aug 04, 2026 | and 7 more | |
Series A | 8188 | Jul 13, 2026 | - | |
Series B | 3822 | Jul 08, 2026 | - |
Top Investors in Artificial Intelligence companies in HealthTech in Asia
General Catalyst is the top investor in Artificial Intelligence companies in HealthTech in Asia based on number of companies invested.
Here are some top investors in Artificial Intelligence companies in HealthTech in Asia:
Investor | Location | Top Portfolio Companies |
|---|---|---|
Cambridge (United States) | - | |
Sunnyvale (United States) | - | |
Redwood City (United States) | - | |
Bengaluru (India) | ||
Menlo Park (United States) | - |
_1583467951837.png?devicePixelRatio=2&height=20&width=20){kind=logo}
M&A activity in Artificial Intelligence companies in HealthTech in Asia
In the year 2024, till December 2024, 1 acquisition happened in Artificial Intelligence companies in HealthTech in Asia.
Here are some recent, important acquisitions in Artificial Intelligence companies in HealthTech in Asia:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | Dec 05, 2024 | ||
Business Acquisition | Aug 10, 2021 | ||
Business Acquisition | Sep 13, 2016 |
Acquisition trends in Artificial Intelligence companies in HealthTech in Asia
Here are the acquisition trends in Artificial Intelligence companies in HealthTech in Asia:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | - |
2025 | - |
2024 | 1 |
2023 | - |
2022 | - |
2021 | 1 |
2020 | - |
2019 | - |
2018 | - |
2017 | - |
IPOs in Artificial Intelligence companies in HealthTech in Asia
In the year 2026, till May 2026, 1 IPO happened in Artificial Intelligence companies in HealthTech in Asia.
Here are some recent, important IPOs in Artificial Intelligence companies in HealthTech in Asia:
Company | IPO Date | Exchange Symbol |
|---|---|---|
May 20, 2026 | Taiwan Stock Exchange (TPE) | |
Jul 25, 2025 | Korea Exchange (KRX) | |
Jan 08, 2025 | Hong Kong Exchanges (HKG) | |
Nov 26, 2024 | Taipei Stock Exchange (TT) | |
Jul 21, 2022 | Korea Exchange (KRX) |
Colleges which produce the most Artificial Intelligence companies in HealthTech in Asia
Companies founded by alumni from top colleges in Artificial Intelligence companies in HealthTech in Asia
Most number of Artificial Intelligence startups in HealthTech in Asia have been founded by alumni from Tel Aviv University, IIT Delhi and National University of Singapore (NUS).
College | No. of companies |
|---|---|
Tel Aviv University | 12 |
IIT Delhi | 6 |
National University of Singapore (NUS) | 6 |
Tsinghua University | 6 |
Carnegie Mellon University | 4 |
IIM Bangalore | 4 |
IIT Bombay | 4 |
IIT Kanpur | 4 |
Stanford University | 4 |
BITS Pilani | 3 |
Total funding in Artificial Intelligence companies founded by alumni from top colleges in HealthTech in Asia
In the last 10 years, graduates from IIT Kharagpur have raised the most funding for Artificial Intelligence companies in HealthTech in Asia, compared to alumni from other top colleges. IIM Ahmedabad alumni are second, and Yale University alumni are third.
College | Total Funding |
|---|---|
IIT Kharagpur | $567M |
IIM Ahmedabad | $557M |
Yale University | $366M |
University of Chicago | $213M |
Columbia University | $200M |
Tel Aviv University | $194M |
IIT Delhi | $137M |
KAIST - Korea Advanced Institute of Science & Technology | $133M |
INSEAD | $115M |
Ben-Gurion University of The Negev | $93.5M |
Top News in Artificial Intelligence companies in HealthTech in Asia
•
•
Lunit and CellCarta to Collaborate on AI-Enabled Digital Pathology WorkflowsContract Pharma•Mar 30, 2026•CellCarta, Lunit
•
Qure.ai Earns FDA OK for 6 New AI Chest X-ray IndicationsMedical Product Outsourcing•Feb 26, 2026•Qure.ai
•
•
•
qXR from Qure.ai obtains regulatory clearance for paediatric TB screeningIndiaMedToday•Oct 17, 2025•Qure.ai
•
Lunit, CellCarta Partner to Expand Digital Pathology AI Access for Clinical TrialsBenzinga•Sep 24, 2025•CellCarta, Lunit
•
•
Akumin Selects Lunit INSIGHT DBT™ to Enhance Nationwide Breast Imaging ServicesPR Newswire•Aug 18, 2025•Akumin, Lunit
•
